Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Medicare Vote Suggests $400 Bil. Rx Benefit Is Winning Formula

Executive Summary

The magic number in the Medicare prescription drug coverage debate appears to be $400 bil. over 10 years
Advertisement

Related Content

CMS “Functional Equivalence” Standard Targeted In Medicare Bills
Medicare Rx Card: Will Drug Discounts Be Permanent Program Fixture?
CMS “Functional Equivalence” Standard Targeted In Medicare Bills
Medicare Rx Law Would Fundamentally Change, Not End, Drug Pricing Debate
Senate AWP Plan Directs HHS To Determine “Market Price” For Chemotherapy
Medicare Rx Law Would Fundamentally Change, Not End, Drug Pricing Debate
Medicare Rx Ready For Committee; Length Of PBM Contracts Is One Issue
Medicare Rx Ready For Committee; Length Of PBM Contracts Is One Issue
Rx Cost-Saving Potential In Medicare Not Yet Demonstrated, CBO Says
Medicare Rx Moves To Campaign Trail; AARP Endorses Stripped Down Bill
Advertisement
UsernamePublicRestriction

Register

PS041983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel